Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $22.9600 (-7.98%) ($22.6600 - $25.3300) on Thu. Dec. 20, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.35% (three month average) | RSI | 26 | Latest Price | $22.9600(-7.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -4.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -7.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(61%) XBI(60%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.175% in a week (0% probabilities). VXX(-13%) VIXM(-10%) GDXJ(-6%) TLT(-4%) SHY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.175% (StdDev 4.35%) | Hourly BBV | 0 () | Intraday Trend | -7.2% | | | |
|
1 - 5 Day Possible Target | $12.95(-43.6%) | Resistance Level | $28.5 | 5 Day Moving Average | $26.06(-11.9%) | 10 Day Moving Average | $27.54(-16.63%) | 20 Day Moving Average | $28.5(-19.44%) | To recent high | -29.5% | To recent low | 0% | Market Cap | $1.426b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |